MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Arnaud Scherpereel, MD
Lille University
Principal Investigator - Marjorie G Zauderer, MD
Memorial Slone Kettering (MSK) Cancer Centre
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
151 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Chermside, Australia
- Research Site
Clayton, Australia
- Research Site
Melbourne, Australia
- Research Site
Nedlands, Australia
- Research Site
Westmead, Australia
- Research Site
Anderlecht, Belgium
- Research Site
Antwerp, Belgium
- Research Site
Ghent, Belgium
- Research Site
Hasselt, Belgium
- Research Site
Sint-Niklaas, Belgium
- Research Site
Barretos, Brazil
- Research Site
Fortaleza, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Rio de Janeiro, Brazil
- Research Site
Santo André, Brazil
- Research Site
São Paulo, Brazil
- Research Site
Edmonton, Alberta, Canada
- Research Site
Ottawa, Ontario, Canada
- Research Site
Toronto, Ontario, Canada
- Research Site
Montreal, Quebec, Canada
- Research Site
Québec, Quebec, Canada
- Research Site
Beijing, China
- Research Site
Beijing, China
- Research Site
Changsha, China
- Research Site
Chengdu, China
- Research Site
Guangzhou, China
- Research Site
Hangzhou, China
- Research Site
Harbin, China
- Research Site
Kunming, China
- Research Site
Lanzhou, China
- Research Site
Ningbo, China
- Research Site
Qingdao, China
- Research Site
Shandong, China
- Research Site
Shanghai, China
- Research Site
Shenyang, China
- Research Site
Taiyuan, China
- Research Site
Taiyuan, China
- Research Site
Tianjin, China
- Research Site
Tianjin, China
- Research Site
Wuhan, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Nov 2023
- Primary completion
- 16 Nov 2028
- Completion
- 16 Nov 2028
- Last update posted
- 9 Jun 2026
- Registered enrollment
- 861
- Registry id
- NCT06097728
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.